4basebio (4BB) Competitors GBX 1,310 +10.00 (+0.77%) (As of 11:20 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider Trades 4BB vs. SLN, OXB, PRTC, HZD, VRP, BVXP, ARIX, AVCT, HVO, and FARNShould you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), Arix Bioscience (ARIX), Avacta Group (AVCT), hVIVO (HVO), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry. 4basebio vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix Arix Bioscience Avacta Group hVIVO Faron Pharmaceuticals Oy 4basebio (LON:4BB) and Silence Therapeutics (LON:SLN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends. Does the media refer more to 4BB or SLN? In the previous week, 4basebio had 4 more articles in the media than Silence Therapeutics. MarketBeat recorded 7 mentions for 4basebio and 3 mentions for Silence Therapeutics. 4basebio's average media sentiment score of 0.81 beat Silence Therapeutics' score of 0.67 indicating that 4basebio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 4basebio 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Silence Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is 4BB or SLN more profitable? Silence Therapeutics' return on equity of 0.00% beat 4basebio's return on equity.Company Net Margins Return on Equity Return on Assets 4basebioN/A -231.29% -54.30% Silence Therapeutics N/A N/A N/A Which has better earnings & valuation, 4BB or SLN? Silence Therapeutics has higher revenue and earnings than 4basebio. 4basebio is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio4basebio£311K539.59-£9.84M-£0.78-1,679.49Silence Therapeutics£11.35M42.34N/A-£48.60-11.01 Do institutionals & insiders believe in 4BB or SLN? 2.0% of 4basebio shares are held by institutional investors. 68.4% of 4basebio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor 4BB or SLN? Silence Therapeutics received 203 more outperform votes than 4basebio when rated by MarketBeat users. CompanyUnderperformOutperform4basebioN/AN/ASilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% Summary4basebio beats Silence Therapeutics on 6 of the 11 factors compared between the two stocks. Ad DTII've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman Get 4basebio News Delivered to You Automatically Sign up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart 4BB vs. The Competition Export to ExcelMetric4basebioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£167.81M£163.76M£5.09B£1.39BDividend YieldN/A3.50%5.04%11.75%P/E Ratio-1,679.49329.4793.091,551.07Price / Sales539.5914,840.741,220.67209,494.22Price / Cash16.0811.6739.4932.97Price / Book-31.957.056.932.81Net Income-£9.84M-£18.37M£118.83M£152.70M7 Day Performance-0.76%0.16%-1.74%-0.48%1 Month Performance-0.30%8.26%-3.60%7.15%1 Year Performance155.86%25.75%31.91%93.19% 4basebio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)4BB4basebioN/AGBX 1,310+0.8%N/A+146.8%£167.81M£311,000.00-1,679.49101Insider TradeNews CoverageSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100High Trading VolumeOXBOxford Biomedica0.9962 of 5 starsGBX 412.50flatGBX 433.33+5.1%+113.7%£434.61M£97.28M-287.15891Gap DownHigh Trading VolumePRTCPureTech HealthN/AGBX 162+0.1%N/A-5.6%£387.86M£3.33M-702.61300HZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,710-1.1%N/A-5.2%£193.66M£13.60M2,298.1612ARIXArix BioscienceN/AGBX 142flatN/A+29.1%£183.73M£14.16M1,290.919AVCTAvacta GroupN/AGBX 46.61+5.3%N/A-67.2%£167.00M£22.62M-532.33120News CoveragePositive NewsHVOhVIVON/AGBX 22.95+3.8%N/AN/A£156.15M£67.21M724.17N/ANews CoverageFARNFaron Pharmaceuticals OyN/AGBX 143.50-2.7%N/A-44.3%£150.13M£-725,000.00-462.5034 Related Companies and Tools Related Companies Silence Therapeutics Competitors Oxford Biomedica Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Verona Pharma plc (VRP.L) Competitors Bioventix Competitors Arix Bioscience Competitors Avacta Group Competitors hVIVO Competitors Faron Pharmaceuticals Oy Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:4BB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free 4BB Stock Alerts